BIOTIE THERAPIES CORP. STOCK EXCHANGE ANNOUNCEMENT 9 January 2007 at 4.15 p.m. NOTIFICATION UNDER CHAPTER 2, SECTION 10 OF THE FINNISH SECURITIES MARKET ACT REGARDING A CHANGE IN HOLDINGS Biotie Therapies Corp. (the Company) has received the following notifications under Chapter 2, Section 9 of the Finnish Securities Market Act regarding a change in holdings: As a result of 11,365,242 new shares being issued on 27 December 2007 by Biotie Therapies Corp., the aggregate holdings of Pequot Healthcare Fund, L.P., Pequot Healthcare Offshore Fund, Inc., Premium Series PCC Limited Cell 32, Pequot Diversified Master Fund, Ltd., Pequot Healthcare Institutional Fund, L.P. and Pequot Healthcare Emerging Markets Fund, Ltd. (jointly, the Funds) have decreased from 25.09% to 23.16% of the share capital and voting rights in the Company, calculated on the basis of the number of shares registered in the Finnish Trade Register. As a result of the new shares being issued, no individual Fund has decreased its holdings below or above 5% of the voting rights and share capital of the company. Shareholder Number of Proportion of shares share capital and voting rights Pequot Healthcare Fund, L.P. 7,213,845 8.06% Pequot Healthcare Offshore Fund, Inc. 5,486,483 6.13% Premium Series PCC Limited 32 Cell 998,490 1.12% Pequot Diversified Master Fund, Ltd. 1,201,800 1.34% Pequot Healthcare Institutional Fund, 1,337,806 1.49% L.P Pequot Healthcare Emerging Markets 4,500,000 5.03% Fund, Ltd. Turku, 9 January 2007 Timo Veromaa President and CEO For further information, please contact: Timo Veromaa, President and CEO, Biotie Therapies Corp. tel. +358 2 274 8901, e-mail: timo.veromaa@biotie.com www.biotie.com DISTRIBUTION The Helsinki Stock Exchange Main Media
NOTIFICATION UNDER CHAPTER 2, SECTION 10 OF THE FINNISH SECURITIES MARKET ACT REGARDING A CHANGE IN
| Source: Biotie Therapies